Previous 10 | Next 10 |
Capricor Therapeutics (NASDAQ: CAPR ) +95% on positive CAP-1002 data . More news on: Capricor Therapeutics, Inc., Galapagos NV, Neon Therapeutics, Inc., Stocks on the move, Read more ...
CD8+ T Cell Reactivity Against 90% of Personalized Neoantigen Targets Confirmed in First of Two Patients Proof-of-Mechanism for Off-the-Shelf ADXS-HOT Program with CD8+ T Cells Against Hotspot Mutations Antigen Spreading Confirmed Advaxis, Inc. (NASDAQ: ADXS), a clini...
Gainers: OMNOVA Solutions (NYSE: OMN ) +55% . SELLAS Life Sciences Group (NASDAQ: SLS ) +46% . Karyopharm Therapeutics (NASDAQ: KPTI ) +36% . One Stop Systems (NASDAQ: OSS ) +26% . NIO (NYSE: NIO ) +15% . Corvus Pharmaceuticals (NASDAQ: CRVS ) +15% . Melinta Therapeutics (NASDA...
Advaxis (NASDAQ: ADXS ) is 6.9% lower after hours following news that it's offering shares through Alliance Global Partners. More news on: Advaxis, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: TSLA +6.8% . NOG +3.0% . SALT +2.9% . ADXS +2.1% . HEAR +1.9% . More news on: Tesla, Inc., Northern Oil and Gas, Inc., Scorpio Bulkers Inc., Stocks on the move, , News on ETFs Read more ...
Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that it is increasing its focus on neoantigen-directed immunotherapies and closing the AIM2CERV Phase 3 clinical trial w...
Gainers: Sotheby's (NYSE: BID ) +58% . Array BioPharma (NASDAQ: ARRY ) +57% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +42% . Vislink Technologies (NASDAQ: VISL ) +40% . MTech Acquisition (NASDAQ: MTEC ) +34% . Endurance International Group Holdings (NASDAQ: EIGI ) +26% . C&am...
Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso...
Gainers: NBY +20.3% . CASY +9.4% . KEG +3.5% . CHAP +3.2% . CXW +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more ...
Advaxis (NASDAQ: ADXS ): Q2 GAAP EPS of -$1.59 misses by $0.02 . More news on: Advaxis, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that it filed a Form 15 with the Securities and Exchange Commission (the “SEC”) to deregister its common stock under Section 12(g) ...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...